VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling.
TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling. J Exp Med. 2014 Jul 28; 211(8):1689-702.
View in:
PubMed
subject areas
Animals
Autoimmunity
Cell Differentiation
Cell Line
Central Nervous System
Encephalomyelitis, Autoimmune, Experimental
Enzyme Activation
Extracellular Signal-Regulated MAP Kinases
Gene Expression Regulation
Hematopoietic System
Humans
Inflammation
Interleukin-17
Lymphocyte Activation
MAP Kinase Kinase Kinases
Mice, Knockout
Phosphorylation
Protein Binding
Proto-Oncogene Proteins
Radiation Tolerance
Signal Transduction
Th17 Cells
authors with profiles
SHAO-CONG SUN
XIAOFEI ZHOU